Results for “”

Entry Author Date Location
Aquam Raises $26M to Expand Tech, Services for Aging Infrastructure 11/10/17 San Diego
FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats 11/07/17 New York
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition 11/01/17 National
As Facebook Fights Fake News, LeCun Sees Bigger Role for A.I. 11/01/17 Boston
As Russians Hacked U.S. Election, Did Big Tech Firms Break Any Laws? 10/30/17 San Francisco
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
Gilt Groupe & Glam Squad’s Wilson Zeroes In On Your Closet With Fitz 10/26/17 New York
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time 10/25/17 New York
As Drugs Fail, Some Researchers Urge a Return to Alzheimer’s Roots 10/25/17 National
Cord Cutting: How to Get High-Speed Internet Without Cable, 2017 Edition 10/25/17 National
Announcing New York Biotech: The Future is Now on Dec. 11 10/24/17 National
JPMorgan Chase to Buy WePay; Venmo Adds Merchant Payments 10/19/17 San Francisco
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
After Trump Sounds Off, Senate Has Adult Conversation on Drug Prices 10/17/17 National
Vinod Khosla on A.I., Health, and the Future of Working (or Not) 10/16/17 San Francisco
JLABS Takes Stock of Its Experiment in Life Sciences Innovation 10/13/17 San Diego
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More 10/13/17 National
Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote 10/12/17 New York
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
FDA To Advisors: What If One-Time Gene Therapy Needs Extra Doses? 10/10/17 National
VC Funding Surges in Fewer Deals in Third Quarter, and Top 10 Deals 10/10/17 National
Blockchain, Banks & the New Web: Q&A With Ethereum Co-founder Lubin 10/10/17 Boston
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
As Relief Moves to Recovery, Questions About FEMA’s Tech Corps 10/05/17 Texas
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
KSQ Bets on CRISPR-Juiced Drug Discovery With $76M & Ex-Genzyme CEO 10/02/17 Boston
FDA Panel Pans PTC’s Audacious Plan to Force Vote on Duchenne Drug 09/28/17 New York
Sumeru Leads $45M Growth Equity Round in Treasury Fintech Kyriba 09/27/17 San Diego
No Effect: Axovant Drug Is Latest Casualty in Alzheimer’s Battle 09/26/17 National
Page 2 of 66 « previous page · next page »